381 related articles for article (PubMed ID: 16900204)
1. Genetic susceptibility to polyI:C-induced IFNalpha/beta-dependent accelerated disease in lupus-prone mice.
Jørgensen TN; Thurman J; Izui S; Falta MT; Metzger TE; Flannery SA; Kappler J; Marrack P; Kotzin BL
Genes Immun; 2006 Oct; 7(7):555-67. PubMed ID: 16900204
[TBL] [Abstract][Full Text] [Related]
2. Type I interferon signaling is involved in the spontaneous development of lupus-like disease in B6.Nba2 and (B6.Nba2 x NZW)F(1) mice.
Jørgensen TN; Roper E; Thurman JM; Marrack P; Kotzin BL
Genes Immun; 2007 Dec; 8(8):653-62. PubMed ID: 17882225
[TBL] [Abstract][Full Text] [Related]
3. BAFF overexpression and accelerated glomerular disease in mice with an incomplete genetic predisposition to systemic lupus erythematosus.
Stohl W; Xu D; Kim KS; Koss MN; Jorgensen TN; Deocharan B; Metzger TE; Bixler SA; Hong YS; Ambrose CM; Mackay F; Morel L; Putterman C; Kotzin BL; Kalled SL
Arthritis Rheum; 2005 Jul; 52(7):2080-91. PubMed ID: 15986357
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
[TBL] [Abstract][Full Text] [Related]
5. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
[TBL] [Abstract][Full Text] [Related]
6. Induction of systemic lupus erythematosus-like syndrome in syngeneic mice by immunization with activated lymphocyte-derived DNA.
Qiao B; Wu J; Chu YW; Wang Y; Wang DP; Wu HS; Xiong SD
Rheumatology (Oxford); 2005 Sep; 44(9):1108-14. PubMed ID: 15840592
[TBL] [Abstract][Full Text] [Related]
7. Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization.
Rudofsky UH; Evans BD; Balaban SL; Mottironi VD; Gabrielsen AE
Lab Invest; 1993 Apr; 68(4):419-26. PubMed ID: 8479150
[TBL] [Abstract][Full Text] [Related]
8. Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice.
Santiago-Raber ML; Dunand-Sauthier I; Wu T; Li QZ; Uematsu S; Akira S; Reith W; Mohan C; Kotzin BL; Izui S
J Autoimmun; 2010 Jun; 34(4):339-48. PubMed ID: 19944565
[TBL] [Abstract][Full Text] [Related]
9. Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice.
Hughes GC; Martin D; Zhang K; Hudkins KL; Alpers CE; Clark EA; Elkon KB
Arthritis Rheum; 2009 Jun; 60(6):1775-84. PubMed ID: 19479860
[TBL] [Abstract][Full Text] [Related]
10. Functional dissection of systemic lupus erythematosus using congenic mouse strains.
Morel L; Mohan C; Yu Y; Croker BP; Tian N; Deng A; Wakeland EK
J Immunol; 1997 Jun; 158(12):6019-28. PubMed ID: 9190957
[TBL] [Abstract][Full Text] [Related]
11. Enhanced susceptibility to end-organ disease in the lupus-facilitating NZW mouse strain.
Xie C; Zhou XJ; Liu X; Mohan C
Arthritis Rheum; 2003 Apr; 48(4):1080-92. PubMed ID: 12687552
[TBL] [Abstract][Full Text] [Related]
12. B cell apoptosis accelerates the onset of murine lupus.
Trébéden-Nègre H; Weill B; Fournier C; Batteux F
Eur J Immunol; 2003 Jun; 33(6):1603-12. PubMed ID: 12778478
[TBL] [Abstract][Full Text] [Related]
13. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
[TBL] [Abstract][Full Text] [Related]
14. IL-4Ralpha polymorphism in regulation of IL-4 synthesis by T cells: implication in susceptibility to a subset of murine lupus.
Shiroiwa W; Tsukamoto K; Ohtsuji M; Lin Q; Ida A; Kodera S; Ohtsuji N; Nakamura K; Tsurui H; Kinoshita K; Nishimura H; Shirai T; Hirose S
Int Immunol; 2007 Feb; 19(2):175-83. PubMed ID: 17189592
[TBL] [Abstract][Full Text] [Related]
15. Lupus nephritis in autoimmune-prone NZB x NZW F1 mice and mechanisms of transition of the glomerular lesions.
Tokado H; Yumura W; Shiota J; Hirose S; Sato H; Shirai T
Acta Pathol Jpn; 1991 Jan; 41(1):1-11. PubMed ID: 2031455
[TBL] [Abstract][Full Text] [Related]
16. Treatment with high doses of anti-IgM prevents, but with lower doses accelerates autoimmune disease in (NZW x BXSB)F1 hybrid mice.
Cerny A; Starobinski M; Hügin AW; Sutter S; Zinkernagel RM; Izui S
J Immunol; 1987 Jun; 138(12):4222-8. PubMed ID: 3495583
[TBL] [Abstract][Full Text] [Related]
17. DNA hypomethylation is crucial for apoptotic DNA to induce systemic lupus erythematosus-like autoimmune disease in SLE-non-susceptible mice.
Wen ZK; Xu W; Xu L; Cao QH; Wang Y; Chu YW; Xiong SD
Rheumatology (Oxford); 2007 Dec; 46(12):1796-803. PubMed ID: 18032537
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of lupus-prone NZM mouse strains to lead exacerbation of systemic lupus erythematosus symptoms.
Hudson CA; Cao L; Kasten-Jolly J; Kirkwood JN; Lawrence DA
J Toxicol Environ Health A; 2003 May; 66(10):895-918. PubMed ID: 12825236
[TBL] [Abstract][Full Text] [Related]
19. Analysis of MHC class II genes in the susceptibility to lupus in New Zealand mice.
Rozzo SJ; Vyse TJ; David CS; Palmer E; Izui S; Kotzin BL
J Immunol; 1999 Mar; 162(5):2623-30. PubMed ID: 10072504
[TBL] [Abstract][Full Text] [Related]
20. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells.
Patole PS; Gröne HJ; Segerer S; Ciubar R; Belemezova E; Henger A; Kretzler M; Schlöndorff D; Anders HJ
J Am Soc Nephrol; 2005 May; 16(5):1326-38. PubMed ID: 15772251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]